PharmaEssentia - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsPharmaEssentia

PharmaEssentia

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

No data

Company Revenue

No data

Revenue by Drug

Marketed Drugs

Therapeutic Areas:

All

Classification:

All

Include Generics:

Trade Name	Drug Name	Approved	Patent Expires	Indication
Besremi	Ropeginterferon alfa-2b	2021-11-12		Polycythemia vera

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

large b-cell lymphoma diffuse

,

multiple myeloma

,

b-cell chronic lymphocytic leukemia

,

follicular lymphoma

,

,

,

,

hodgkin disease

,

mantle-cell lymphoma

,

b-cell lymphoma

,

triple negative breast neoplasms

,

renal cell carcinoma

,

,

,

,

chronic hepatitis b

,

communicable diseases

,

,

parkinson disease

,

parkinsonian disorders

,

movement disorders

,

,

,

giant cell arteritis

,

polymyalgia rheumatica

,

chronic renal insufficiency

,

,

pituitary acth hypersecretion

,

acth-secreting pituitary adenoma

,

graft vs host disease

,

type 1 diabetes mellitus

,

,

prostatic neoplasms

,

castration-resistant prostatic neoplasms

,

brain neoplasms

,

,

oligodendroglioma

,

pancreatic neoplasms

,

,

neuroendocrine tumors

,

islet cell carcinoma

,

,

,

somatostatinoma

,

,

,

breast neoplasms

,

myelodysplastic syndromes

,

thrombocytopenia

,

,

,

,

retinal vein occlusion

,

vision disorders

,

,

macular degeneration

,

thrombocytopenic purpura idiopathic

,

thrombocytopenic purpura

,

,

juvenile arthritis

,

,

kidney diseases

,

myocardial infarction

,

,

inferior wall myocardial infarction

,

organ transplantation

,

wet macular degeneration

,

neoplasm metastasis

,

graft rejection

,

chronic obstructive pulmonary disease

,

,

obstructive lung diseases

,

,

non-alcoholic fatty liver disease

,

,

postoperative pain

,

,

choroidal neovascularization

,

pathologic neovascularization

,

chronic kidney failure

,

renal insufficiency

,

liver transplantation

,

kidney transplantation

,

,

,

,

ankylosing spondylitis

,

spondylarthritis

,

,

liver cirrhosis

,

,

atrial fibrillation

Calcium carbonate

,

postmenopausal osteoporosis

factor vii deficiency

,

healthy volunteers/patients

,

systemic scleroderma

,

diffuse scleroderma

,

,

,

,

graft vs host disease

,

,

polyneuropathies

,

chronic inflammatory demyelinating polyradiculoneuropathy

,

polyradiculoneuropathy

,

afibrinogenemia

,

dermatomyositis

,

alpha 1-antitrypsin deficiency

,

acute coronary syndrome

,

postural orthostatic tachycardia syndrome

,

Antithrombin iii

,

,

immunologic deficiency syndromes

,

primary immunodeficiency diseases

,

,

postoperative hemorrhage

,

surgical blood loss

,

colorectal neoplasms

,

squamous cell neoplasms

,

,

head and neck neoplasms

,

pancreatic ductal carcinoma

,

triple negative breast neoplasms

,

,

merkel cell carcinoma

,

mycosis fungoides

,

gastrointestinal neoplasms

,

digestive system neoplasms

,

gastrointestinal stromal tumors

,

neoplasm metastasis

,

pancreatic neoplasms

,

endometrial neoplasms

,

stomach neoplasms

,

esophageal neoplasms

,

bile duct neoplasms

,

hepatocellular carcinoma

,

liver neoplasms

,

,

,

renal cell carcinoma

,

ovarian neoplasms

,

urologic neoplasms

,

,

breast neoplasms

,

,

fallopian tube neoplasms

,

ovarian epithelial carcinoma

,

peritoneal neoplasms

,

transitional cell carcinoma

,

neoadjuvant therapy

,

kidney diseases

,

urogenital neoplasms

,

kidney neoplasms

,

urologic diseases

,

neoplasms by site

,

glandular and epithelial neoplasms

,

non-small-cell lung carcinoma

,

,

squamous cell carcinoma of head and neck

,

urinary bladder neoplasms

,

squamous cell carcinoma

,

non-muscle invasive bladder neoplasms

,

disease progression

insulin resistance

,

autoimmune diseases of the nervous system

,

,

nervous system malformations

,

kidney diseases

,

,

,

chronic hepatitis d

,

,

herpesviridae infections

,

,

patient acceptance of health care

,

multiple sclerosis

,

,

relapsing-remitting multiple sclerosis

,

,

drug-related side effects and adverse reactions

,

leukoencephalopathies

,

progressive multifocal leukoencephalopathy

,

hepatitis b virus

,

,

,

,

treatment adherence and compliance

,

,

hepatocellular carcinoma

,

liver neoplasms

,

,

,

,

,

,

chronic hepatitis b

,

acquired immunodeficiency syndrome

,

,

chronic hepatitis

,

,

communicable diseases

,

immunologic deficiency syndromes

,

,

,

medication adherence

,

,

substance-related disorders

,

,

patient compliance

,

healthy volunteers/patients

,

,

chronic renal insufficiency

,

renal insufficiency

,

,

persistent infection

,

cognitive dysfunction

,

chronic hepatitis c

,

,

metabolic diseases

,

,

,

kidney transplantation

,

non-hodgkin lymphoma

,

burkitt lymphoma

,

,

,

neurocognitive disorders

,

sleep wake disorders

,

,

,

anxiety disorders

,

opioid-related disorders

,

metabolic bone diseases

,

,

morphine dependence

,

hiv seronegativity

,

,

,

,

recreational drug use

,

hiv seropositivity

,

,

liver cirrhosis

,

,

biliary liver cirrhosis

,

,

,

cardiovascular diseases

,

retinal diseases

,

metabolic syndrome

,

drug interactions

Albinterferon alfa-2b

kidney neoplasms

,

communicable diseases

,

,

renal cell carcinoma

,

,

brain neoplasms

,

gastrointestinal stromal tumors

,

cholangiocarcinoma

,

primary myelofibrosis

,

,

,

,

hereditary hemorrhagic telangiectasia

,

,

pancreatic neoplasms

,

,

,

,

bcr-abl positive chronic myelogenous leukemia

,

,

myeloid leukemia

,

acquired immunodeficiency syndrome

,

,

,

,

,

neoadjuvant therapy

,

hepatocellular carcinoma

,

liver neoplasms

,

chronic hepatitis d

,

,

liver transplantation

,

,

depressive disorder

,

neoplasm metastasis

,

disease progression

,

,

,

,

chronic hepatitis c

,

chronic hepatitis

,

,

liver cirrhosis

,

,

chronic hepatitis b

,

,

,

,

chronic kidney failure

,

kidney diseases

,

,

insulin resistance

,

,

substance-related disorders

,

intravenous substance abuse

,

,

cutaneous malignant melanoma

,

non-hodgkin lymphoma

,

,

follicular lymphoma

polyneuropathies

,

chronic inflammatory demyelinating polyradiculoneuropathy

,

polyradiculoneuropathy

,

,

alpha 1-antitrypsin deficiency

,

pulmonary emphysema

,

© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use